Kimelman & Baird’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,734
Closed -$220K – 262
2026
Q2
$220K Hold
9,734
– – 0.02% 112
2026
Q1
$220K Hold
9,734
– – 0.02% 109
2025
Q4
$232K Hold
9,734
– – 0.02% 110
2025
Q3
$256K Hold
9,734
– – 0.02% 108
2025
Q2
$278K Hold
9,734
– – 0.02% 111
2025
Q1
$242K Hold
9,734
– – 0.02% 116
2024
Q4
$220K Hold
9,734
– – 0.02% 120
2024
Q3
$207K Hold
9,734
– – 0.02% 125
2024
Q2
$186K Buy
+9,734
New +$198K 0.02% 131
2021
Q2
$677K Buy
+16,280
New +$651K 0.06% 73
2019
Q3
$547K Hold
16,280
– – 0.08% 69
2019
Q2
$639K Hold
16,280
– – 0.09% 71
2019
Q1
$660K Hold
16,280
– – 0.09% 68
2018
Q4
$527K Hold
16,280
– – 0.08% 72
2018
Q3
$837K Hold
16,280
– – 0.11% 66
2018
Q2
$820K Buy
+16,280
New +$825K 0.11% 69
2017
Q4
$856K Hold
16,280
– – 0.12% 65
2017
Q3
$796K Hold
16,280
– – 0.12% 65
2017
Q2
$787K Hold
16,280
– – 0.12% 67
2017
Q1
$686K Hold
16,280
– – 0.1% 69
2016
Q4
$687K Hold
16,280
– – 0.12% 66
2016
Q3
$713K Hold
16,280
– – 0.13% 67
2016
Q2
$709K Hold
16,280
– – 0.13% 66
2016
Q1
$718K Hold
16,280
– – 0.13% 67
2015
Q4
$681K Buy
+16,280
New +$686K 0.13% 73
2015
Q2
$677K Buy
+16,280
New +$696K 0.12% 78

Other funds holding FMS

Kimelman & Baird's FMS Position: Q3 2026 in Review

Kimelman & Baird sold out of Fresenius Medical Care (FMS) in Q3 2026, closing a stake of 9,734 shares — an estimated $220K sold.

Kimelman & Baird first reported a position in FMS in Q2 2015 and held it in 26 quarters. The position peaked at $856K in Q4 2017. 229 funds tracked by Wall St. Rank hold FMS as of Q3 2026.

  • Kimelman & Baird reported no remaining Fresenius Medical Care position as of Q3 2026 after selling out during the quarter.
  • Kimelman & Baird sold 9,734 Fresenius Medical Care shares in Q3 2026, an estimated $220K.
  • Kimelman & Baird first reported a position in Fresenius Medical Care in Q2 2015 and held it in 26 quarters.
  • Kimelman & Baird's Fresenius Medical Care position peaked at $856K in Q4 2017.
  • 229 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.

Based on Kimelman & Baird's 13F filing for Q3 2026, filed 3 Nov 2026.